Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Stockholders Equity Over TimeStable
Percentile Rank44
3Y CAGR-14.8%
5Y CAGR-5.6%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-14.8%/yr
vs -18.2%/yr prior
5Y CAGR
-5.6%/yr
Recent deceleration
Acceleration
+3.4pp
Accelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $24.74M | +350.9% |
| 2024 | $-9.86M | -149.9% |
| 2023 | $19.76M | -50.6% |
| 2022 | $40.03M | +22.8% |
| 2021 | $32.60M | -1.2% |
| 2020 | $32.99M | -49.3% |
| 2019 | $65.02M | -27.3% |
| 2018 | $89.43M | +1370.1% |
| 2017 | $-7.04M | -164.3% |
| 2016 | $-2.66M | - |